May 2024 – content
Life Sciences
Cell culture media expert joins Ampersand’s portfolio
Acquisitions benefit Porvair’s Laboratory and Aerospace & Industrial divisions
Ampersand invests in cryo-EM services company
Antibody manufacturer sold to equity firm
Acquisition of digital microfluidics firm to solidify Integra Bio’s pandemic growth
BioLabs enters partnership with SPT Labtech
General Laboratory
Spectroscopy accessories pioneers combine with equity investment help
Indutrade buys two analytics-focussed companies
ARC sells exclusive rights to catalytic microreactor products
Anton Paar opens two more foreign subsidiaries
Excelitas moves headquarters
Process & hand-held instrumentation
Sartorius expands global manufacturing capacity
Sick and E+H to create JV targeting cleaner industries
Financials
Instrument sales up at Standard BioTools on eve of merger
Perfect mix of trends put Bio-Rad LS into tail spin
Demand reduction hits Sartorius after three years of growth
Porvair Laboratory sees organic sales reductions
Takara Bio hits the pandemic buffers
Chinese and pharma weakness forces Waters into decline
Specac continues pandemic recovery with reduced growth rates
Beijing Labtech doubles R&D spend
Logistics delays strike Mettler-Toledo in the fourth quarter
Destocking causes blip in Trajan’s growth history
Elementar sees sharp drop of extra-EU sales in 2021
Acquisition helps Getinge LS to report growth in 2023
Sick misses 2023 growth target
OSI Systems growth powered by Security division
Process automation sole source of growth for E+H in 2023
Changes at Leidos may result in spot light on SES
Smiths Detection’s growth led by other security applications
Appointments
